发明授权
![N-[4-(heteroarylmethyl)phenyl]-heteroarylamines](/docs/US/2008-05-27/US07378433B2/abs.jpg.600x600.jpg)
- 专利标题： N-[4-(heteroarylmethyl)phenyl]-heteroarylamines
- 专利标题（中）： N- [4-（杂芳基甲基）苯基] - 杂芳基胺
-
申请号： US11639043申请日： 2006-12-13
-
公开(公告)号： US07378433B2公开(公告)日： 2008-05-27
- 发明人: Marc Gaston Venet , Dominique Jean-Pierre Mabire , Jean Fernand Armand Lacrampe , Gerard Charles Sanz
- 申请人： Marc Gaston Venet , Dominique Jean-Pierre Mabire , Jean Fernand Armand Lacrampe , Gerard Charles Sanz
- 申请人地址： BE Beerse
- 专利权人： Janssen Pharmaceutica, N.V.
- 当前专利权人： Janssen Pharmaceutica, N.V.
- 当前专利权人地址： BE Beerse
- 代理机构： Woodcock Washburn LLP
- 优先权： EP96201781 19960627
- 主分类号： A61K31/425
- IPC分类号： A61K31/425 ; C07D257/04
![N-[4-(heteroarylmethyl)phenyl]-heteroarylamines](/abs-image/US/2008/05/27/US07378433B2/abs.jpg.150x150.jpg)
摘要：
The present invention is concerned with compounds of formula the N-oxides, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein R1 is hydrogen, hydroxy, C1-6alkyl or aryl; R2 is hydrogen; optionally substituted C1-12alkyl; C3-7cycloalkyl; C2-8alkenyl, optionally substituted pyrrolidinyl or aryl; R3 is hydrogen, optionally substituted C1-6alkyl or aryl; Het is an optionally substituted unsaturated heterocycle selected from imidazolyl, triazolyl, tetrazolyl and pyridinyl; is an optionally substituted unsaturated mono- or bicyclic heterocycle; and aryl is optionally substituted phenyl. The present invention also relates to processes for their preparation and compositions comprising said new compounds, as well as their use as a medicine.
公开/授权文献
- US20070088062A1 N-[4-(heteroarylmethyl)phenyl]-heteroarylamines 公开/授权日：2007-04-19
信息查询
